David Dintenfass - 01 May 2026 Form 4 Insider Report for HUMANA INC (HUM)

Reporting relationship: President, Enterprise Growth
Issuer ticker: HUM
Reported as of: 01 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 May 2026, 15:54:55 UTC
Prior SEC filing: 24 Feb 2026
Source filing: View source filing
Reporting owner signature: David Dintenfass

Key filing fact

David Dintenfass filed Form 4 for HUMANA INC (HUM) on 05 May 2026.

Key facts

This page summarizes David Dintenfass's Form 4 filing for HUMANA INC (HUM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 May 2026, 15:54.

Change

Previous filing in this sequence was filed on 24 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002010288 Primary reporting owner

Dintenfass David

Relationship: President, Enterprise Growth
Address: HUMANA INC., 101 E. MAIN STREET, LOUISVILLE
Signature: David Dintenfass
Signature date: 05 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM transaction

Humana Common

Award

Transaction value
Shares: +11,273
Change %: +80%
Price: $0.000000^*
Shares after: 25,407
Date: 01 May 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 51,389
Date: 01 May 2026
Ownership: Direct
Underlying class: Humana Common
Underlying amount: 51,389
Exercise price: $367.21
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Footnote F2

Includes 18,617 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.